Clearmind Medicine Inc. Common Shares (CMND) — Cash Flow-to-Debt Ratio
Clearmind Medicine Inc. Common Shares (CMND) has a Cash Flow-to-Debt Ratio of -0.72x as of January 2026, meaning its operating cash flow of $-2.08 Million could theoretically repay -1% of its total liabilities ($2.90 Million) in one year. See Clearmind Medicine Inc. Common Shares free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Clearmind Medicine Inc. Common Shares Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Clearmind Medicine Inc. Common Shares across 12 annual periods. Also explore Clearmind Medicine Inc. Common Shares annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Clearmind Medicine Inc. Common Shares (2014–2025)
Year-by-year debt coverage analysis for Clearmind Medicine Inc. Common Shares. For market capitalisation and broader financial context, see Clearmind Medicine Inc. Common Shares market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.97x | $-4.73 Million | $4.89 Million | ▲ +17.4% |
| 2024 | -1.17x | $-6.76 Million | $5.77 Million | ▲ +7.6% |
| 2023 | -1.27x | $-6.30 Million | $4.97 Million | ▲ +34.2% |
| 2022 | -1.93x | $-5.06 Million | $2.62 Million | ▲ +73.3% |
| 2021 | -7.21x | $-2.08 Million | $288.19K | ▲ +63.6% |
| 2020 | -19.79x | $-198.50K | $10.03K | ▼ -1299.9% |
| 2019 | -1.41x | $-47.85K | $33.85K | ▲ +89.8% |
| 2018 | -13.82x | $-80.48K | $5.83K | ▼ -7665.7% |
| 2017 | -0.18x | $-9.12K | $51.28K | ▲ +42.1% |
| 2016 | -0.31x | $-15.37K | $50.01K | ▲ +83.2% |
| 2015 | -1.83x | $-39.81K | $21.76K | ▼ -105.2% |
| 2014 | -0.89x | $-28.01K | $31.43K | — |